A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages

Early diagnosis of Alzheimer’s disease (AD) is a crucial starting point in disease management. Blood-based biomarkers could represent a considerable advantage in providing AD-risk information in primary care settings. Here, we report new data for a relatively unknown blood-based biomarker that holds...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Pers Med
Egile Nagusiak: Abate, Giulia, Vezzoli, Marika, Polito, Letizia, Guaita, Antonio, Albani, Diego, Marizzoni, Moira, Garrafa, Emirena, Marengoni, Alessandra, Forloni, Gianluigi, Frisoni, Giovanni B., Cummings, Jeffrey L., Memo, Maurizio, Uberti, Daniela
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7823360/
https://ncbi.nlm.nih.gov/pubmed/33375220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11010014
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak